Related Experiment Video
Updated: Jan 10, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
[Marfan syndrome].
Ilkka Kaitila1, Eero Jokinen, Jorma Kokkonen
1Helsingin yliopisto, lääketieteellisen genetiikan osasto.
Marfan syndrome presents with varied symptoms and is diagnosed using updated criteria. Research into its genetic causes and new treatments like ATR-blockers is ongoing for better patient care.
Area of Science:
- Genetics and Molecular Biology
- Cardiovascular Medicine
- Clinical Diagnostics
Background:
- Marfan syndrome is a genetic disorder affecting connective tissue.
- Clinical presentation shows significant heterogeneity and variability.
- The FBN1 gene is implicated in Marfan syndrome and other aortic conditions.
Purpose of the Study:
- To review Marfan syndrome's clinical heterogeneity, diagnostic criteria, etiology, and treatment options.
- To discuss the role of FBN1 gene mutations in differentiating Marfan syndrome.
- To explore novel therapeutic targets and management strategies.
Main Methods:
- Literature review focusing on clinical heterogeneity, diagnostic criteria (2010 expert group), molecular etiology, and treatment.
- Analysis of FBN1 gene mutations and their role in differential diagnosis.
- Examination of cellular TGF-beta-signaling pathways in pathogenesis.
Main Results:
- Updated diagnostic criteria (2010) aid in distinguishing Marfan syndrome from other aortic syndromes.
- FBN1 gene mutations are key diagnostic markers.
- Cellular TGF-beta-signaling offers potential new therapeutic avenues, though evidence is limited.
Conclusions:
- Marfan syndrome diagnosis relies on clinical findings, family history, and FBN1 gene analysis.
- Targeting TGF-beta-signaling presents a promising, albeit unproven, medical treatment approach.
- A structured approach to diagnosis, treatment, and follow-up is essential for Marfan patients, with specific considerations for the Finnish healthcare system.
More Related Videos
06:48Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
Related Concept Videos
Sex-linked Disorders
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Aneurysm I: Introduction
Mitral Valve Prolapse I: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...